Anti-inflammatory Property of Indomethacin Against Carrageenan-Induced Paw Oedema
1. Aim
To interpret the syllabus-listed anti-inflammatory property of indomethacin against carrageenan-induced paw oedema from an approved video, archival record, or simulation. Actual experimental result must be entered in the student record.
2. Requirements
Instructor-approved, de-identified record or simulation; protocol and ethical authorization reference; control and test labels; defined outcome and units; quality and welfare notes; observation sheet. Actual drug amount, exposure, animal preparation, timing, and endpoint criteria are to be recorded from the approved protocol or instructor-supplied dataset in the student record from the approved protocol.
3. Theory
The model compares paw swelling over time under control and treatment conditions. The outcome is a measured change, not the presence or absence of inflammation. Baseline size, time point, measurement method, allocation, and welfare records all affect interpretation. A smaller swelling measure alone does not establish clinical benefit.
4. Procedure
- Confirm the exact syllabus entry and the institutional approval status of the source record.
- Transcribe model, intervention, control, outcome units, time points, and any missing fields.
- Read approved control and treatment records at matched time points. Compute change from baseline for each record and compare groups only with the stated statistical method.
- Check baseline quality, blinding or allocation notes, measurement validity, and welfare information.
- Calculate only from accepted matching records; write Record here wherever method information is missing.
- Report the supported observation and limits without making a treatment or safety claim.
5. Observation and calculation
| Student record field | Entry |
|---|---|
| Case or product | Record here |
| Method | Record here |
| Observation | Record here |
| Inference | Record here |
| Supervisor check | Record here |
| Outcome | Record here |
Assumed values or observations for practice only: Assumed baseline paw measure 2.0 arbitrary units and assumed later measure 2.5 units give an assumed change of 0.5 units. This is invented practice data, not an animal measurement. Every invented input and output is assumed, never a dose, exposure instruction, or actual result.
6. Output or final result
Present a labelled baseline to follow-up chart and conditional finding. Actual outcome: Record here.
Teaching-lab safety: Use only approved recordings or simulations. Any live-animal, toxicant, or isolated-organ work requires ethical authorization, trained staff, and institution-specific safety controls. No exposure or dosing procedure is provided.
This page is a supervised-activity guide; it does not report a completed case.
7. Sources
- PharmacoLearn Pharm.D Year 3 syllabus
- PCI Pharm.D Regulations and Syllabus
- CCSEA Acts, Rules and Guidelines
- NC3Rs, The 3Rs
- ARRIVE 2.0 Guidelines
Back to Pharmacology-II Practicals · All Pharm D Practicals · Pharm D
Theory notes: Pharmacology II
